Concepedia

Agnès Bénardeau

AB

35

Publications

1.7K

Citations

25

H-Index

1995

Active since

Affiliations

Roche (Switzerland)(Current)

Bayer (Germany)

RWTH Aachen University

Medizinische Hochschule Hannover

Hôpital Marie Lannelongue

Agnès Bénardeau is an author at Roche (Switzerland) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1995–2023

35

Publications

35

Nitric oxide regulates the calcium current in isolated human atrial myocytes.

Michael Kirstein, M. Rivet-Bastide, Stéphane Hatem et al. · Journal of Clinical Investigation · 1995 · 195 citations · Full text

The T-Type Ca<sup>2+</sup>Channel Blocker Mibefradil Prevents the Development of a Substrate for Atrial Fibrillation by Tachycardia-Induced Atrial Remodeling in Dogs

Samir Fareh, Agnès Bénardeau, Bernard Thibault et al. · Circulation · 1999 · 156 citations

cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.

M. Rivet-Bastide, Grégoire Vandecasteele, Stéphane Hatem et al. · Journal of Clinical Investigation · 1997 · 125 citations · Full text

Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial Fibrillation

Danshi Li, Agnès Bénardeau, Stanley Nattel · Circulation · 2000 · 107 citations · Full text

Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes

Agnès Bénardeau, Jörg Benz, Alfred Binggeli et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 103 citations · Full text

, , +7

Rows per page

1–5 of 35